T Maehara Selected Research

T Maehara Research Topics

6	Neoplasms (Cancer) 02/2012 - 01/2000
5	Hemorrhage 01/2009 - 01/2000
3	Esophageal Neoplasms (Esophageal Cancer) 02/2012 - 01/2001
2	Sialadenitis 03/2015 - 10/2014
2	Dacryocystitis (Dacryoadenitis) 03/2015 - 10/2014
2	Lung Neoplasms (Lung Cancer) 10/2003 - 06/2002
2	Neoplasm Metastasis (Metastasis) 06/2002 - 01/2001
2	Carcinoma (Carcinomatosis) 01/2001 - 01/2001
2	Drug Resistant Epilepsy 09/2000 - 09/2000
2	Fever (Fevers) 05/2000 - 01/2000
1	Germinoma 01/2020
1	Immunoglobulin G4-Related Disease 07/2019
1	Mikulicz' Disease 03/2015
1	Xerostomia 03/2015
1	Lymphatic Metastasis 01/2007
1	Cerebral Infarction 10/2003
1	Fistula 10/2003
1	Respiratory Insufficiency (Respiratory Failure) 10/2003
1	Pulmonary Infarction 10/2003
1	Pathologic Constriction (Stenosis) 09/2003
1	Experimental Melanoma 06/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2001
1	Neuroblastoma 08/2001
1	Sphingolipidoses (Sphingolipidosis) 08/2001
1	Vertigo (Positional Vertigo) 08/2001
1	Stroke (Strokes) 07/2001
1	Biliary Atresia 10/2000
1	Hemimegalencephaly 09/2000
1	Hemolysis 06/2000
1	Multiple Myeloma 05/2000
1	Aneurysm (Aneurysms) 03/2000
1	Intracranial Aneurysm (Cerebral Aneurysm) 03/2000
1	Breast Neoplasms (Breast Cancer) 01/2000
1	Arthralgia (Joint Pain) 01/2000

2	Immunoglobulin G (IgG)IBA 03/2015 - 10/2014
2	HydrogelsIBA 05/2007 - 11/2001
2	ChitosanIBA 05/2007 - 11/2001
1	RNA (Ribonucleic Acid)IBA 07/2019
1	Secretory Immunoglobulin A (SIgA)IBA 03/2015
1	CytokinesIBA 03/2015
1	AntioxidantsIBA 02/2012
1	Oxidants (Oxidizing Agents)IBA 02/2012
1	SolutionsIBA 01/2009
1	Hyaluronic Acid (Hyaluronan)IBA 05/2007
1	GadoliniumIBA 09/2003
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2002
1	matrigelIBA 06/2002
1	NAC-HCPSIBA 06/2002
1	Polystyrenes (Polystyrene)IBA 06/2002
1	AnticoagulantsIBA 06/2002
1	metaperiodate (periodate)IBA 06/2002
1	Heparin (Liquaemin)FDA LinkGeneric 06/2002
1	Tissue Adhesives (Tissue Adhesive)IBA 11/2001
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 09/2001
1	SphingolipidsIBA 08/2001
1	Caspase 3 (Caspase-3)IBA 08/2001
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2001
1	Indicators and Reagents (Reagents)IBA 10/2000
1	Oxidoreductases (Dehydrogenase)IBA 05/2000
1	Interleukin-6 (Interleukin 6)IBA 05/2000
1	Tamoxifen FDA LinkGeneric 01/2000
1	EnzymesIBA 01/2000
1	Analgesics (Analgesic Drugs)IBA 01/2000
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2000
1	Prednisolone (Predate)FDA LinkGeneric 01/2000

5	Therapeutics 02/2012 - 01/2000
2	Neoadjuvant Therapy 02/2012 - 01/2007
2	Enteral Nutrition (Feeding, Tube) 02/2012 - 01/2001
2	Thoracotomy 10/2003 - 01/2000
2	Transcranial Magnetic Stimulation 07/2001 - 09/2000
2	Hemispherectomy 09/2000 - 09/2000
1	Immunotherapy 01/2020
1	Drug Therapy (Chemotherapy) 02/2012
1	Operative Surgical Procedures 02/2012
1	Radiotherapy 01/2007
1	Artificial Respiration (Mechanical Ventilation) 10/2003
1	Segmental Mastectomy (Lumpectomy) 10/2003
1	Punctures 11/2001
1	Parenteral Nutrition 01/2001
1	Contraindications 01/2001
1	Liver Transplantation 10/2000
1	Ventriculoperitoneal Shunt 09/2000
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 06/2000
1	Craniotomy 03/2000
1	Aftercare (After-Treatment) 01/2000